Colleen Sweeney

6.0k total citations
81 papers, 4.3k citations indexed

About

Colleen Sweeney is a scholar working on Molecular Biology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Colleen Sweeney has authored 81 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Molecular Biology, 26 papers in Oncology and 15 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Colleen Sweeney's work include HER2/EGFR in Cancer Research (18 papers), Glycosylation and Glycoproteins Research (16 papers) and Monoclonal and Polyclonal Antibodies Research (15 papers). Colleen Sweeney is often cited by papers focused on HER2/EGFR in Cancer Research (18 papers), Glycosylation and Glycoproteins Research (16 papers) and Monoclonal and Polyclonal Antibodies Research (15 papers). Colleen Sweeney collaborates with scholars based in United States, Japan and Germany. Colleen Sweeney's co-authors include Kermit L. Carraway, Jamie K. Miller, David L. Shattuck, David W. Meinke, Lily Yen, Xiuli Wu, William Beutler, Melanie B. Laederich, William Fry and Allan W. Dickerman and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and SHILAP Revista de lepidopterología.

In The Last Decade

Colleen Sweeney

81 papers receiving 4.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Colleen Sweeney United States 40 2.4k 1.2k 581 534 503 81 4.3k
Raj K. Pandita United States 42 4.2k 1.7× 774 0.6× 294 0.5× 165 0.3× 165 0.3× 108 5.9k
Susan Smith United States 50 5.2k 2.1× 1.8k 1.4× 368 0.6× 305 0.6× 369 0.7× 116 8.9k
Rodrigo Bravo United States 37 3.2k 1.3× 1.2k 0.9× 413 0.7× 305 0.6× 364 0.7× 60 6.5k
Homayoun Vaziri Canada 19 4.0k 1.6× 1.2k 0.9× 411 0.7× 143 0.3× 173 0.3× 25 8.4k
Jun Kudoh Japan 44 3.2k 1.3× 439 0.4× 542 0.9× 284 0.5× 349 0.7× 150 7.9k
Ludger Klein‐Hitpaß Germany 48 4.9k 2.0× 1.3k 1.1× 537 0.9× 208 0.4× 778 1.5× 160 8.3k
Kevin D. Brown United States 46 3.9k 1.6× 1.4k 1.1× 370 0.6× 87 0.2× 429 0.9× 90 5.6k
Jolene J. Windle United States 43 4.5k 1.9× 2.5k 2.0× 286 0.5× 175 0.3× 389 0.8× 137 7.7k
Robert P. C. Shiu Canada 43 3.3k 1.4× 1.4k 1.1× 548 0.9× 280 0.5× 269 0.5× 102 6.7k
Qiang Wang China 32 1.6k 0.6× 939 0.8× 224 0.4× 122 0.2× 202 0.4× 151 3.5k

Countries citing papers authored by Colleen Sweeney

Since Specialization
Citations

This map shows the geographic impact of Colleen Sweeney's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Colleen Sweeney with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Colleen Sweeney more than expected).

Fields of papers citing papers by Colleen Sweeney

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Colleen Sweeney. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Colleen Sweeney. The network helps show where Colleen Sweeney may publish in the future.

Co-authorship network of co-authors of Colleen Sweeney

This figure shows the co-authorship network connecting the top 25 collaborators of Colleen Sweeney. A scholar is included among the top collaborators of Colleen Sweeney based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Colleen Sweeney. Colleen Sweeney is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kado, Sarah Y., Keith J. Bein, Alejandro R. Castañeda, et al.. (2023). Regulation of IDO2 by the Aryl Hydrocarbon Receptor (AhR) in Breast Cancer. Cells. 12(10). 1433–1433. 12 indexed citations
2.
Sweeney, Colleen, Gwendal Lazennec, & Christoph F. A. Vogel. (2022). Environmental exposure and the role of AhR in the tumor microenvironment of breast cancer. Frontiers in Pharmacology. 13. 1095289–1095289. 21 indexed citations
3.
Simion, Catalina, Neelu Batra, Anastasia L. Berg, et al.. (2019). A Novel Bioengineered miR-127 Prodrug Suppresses the Growth and Metastatic Potential of Triple-Negative Breast Cancer Cells. Cancer Research. 80(3). 418–429. 49 indexed citations
4.
Tepper, Clifford G., et al.. (2019). A Syngeneic ErbB2 Mammary Cancer Model for Preclinical Immunotherapy Trials. Journal of Mammary Gland Biology and Neoplasia. 24(2). 149–162. 8 indexed citations
5.
Hatakeyama, Jason, Catalina Simion, Mingshui Chen, et al.. (2015). LRIG1 opposes epithelial-to-mesenchymal transition and inhibits invasion of basal-like breast cancer cells. Oncogene. 35(22). 2932–2947. 31 indexed citations
6.
Candas, Demet, Ming Fan, Frank Y.S. Chuang, et al.. (2014). Mitochondrial MKP1 Is a Target for Therapy-Resistant HER2-Positive Breast Cancer Cells. Cancer Research. 74(24). 7498–7509. 39 indexed citations
7.
8.
Littlepage, Laurie E., Adam S. Adler, Hosein Kouros‐Mehr, et al.. (2012). The Transcription Factor ZNF217 Is a Prognostic Biomarker and Therapeutic Target during Breast Cancer Progression. Cancer Discovery. 2(7). 638–651. 54 indexed citations
9.
Krig, Sheryl R., Seth Frietze, Catalina Simion, et al.. (2011). Lrig1 Is an Estrogen-Regulated Growth Suppressor and Correlates with Longer Relapse-Free Survival in ERα-Positive Breast Cancer. Molecular Cancer Research. 9(10). 1406–1417. 54 indexed citations
10.
Miller, Jamie K., Heather C. Workman, Lily Yen, et al.. (2010). Post-transcriptional Mechanisms Contribute to the Suppression of the ErbB3 Negative Regulator Protein Nrdp1 in Mammary Tumors. Journal of Biological Chemistry. 285(37). 28691–28697. 21 indexed citations
11.
Trainor, Brian C., Colleen Sweeney, & Robert D. Cardiff. (2009). Isolating the Effects of Social Interactions on Cancer Biology. Cancer Prevention Research. 2(10). 843–846. 2 indexed citations
12.
Khan, Imran, Jing Zhao, P. Ghosh, et al.. (2009). Microbead Arrays for the Analysis of ErbB Receptor Tyrosine Kinase Activation and Dimerization in Breast Cancer Cells. Assay and Drug Development Technologies. 8(1). 27–36. 7 indexed citations
13.
Shattuck, David L., et al.. (2006). LRIG1 Is a Novel Negative Regulator of the Met Receptor and Opposes Met and Her2 Synergy. Molecular and Cellular Biology. 27(5). 1934–1946. 100 indexed citations
14.
Sweeney, Colleen, Jamie K. Miller, David L. Shattuck, & Kermit L. Carraway. (2006). ErbB Receptor Negative Regulatory Mechanisms: Implications in Cancer. Journal of Mammary Gland Biology and Neoplasia. 11(1). 89–99. 16 indexed citations
15.
Carraway, Kermit L. & Colleen Sweeney. (2006). Co-opted integrin signaling in ErbB2-induced mammary tumor progression. Cancer Cell. 10(2). 93–95. 21 indexed citations
16.
Laederich, Melanie B., et al.. (2004). The Leucine-rich Repeat Protein LRIG1 Is a Negative Regulator of ErbB Family Receptor Tyrosine Kinases. Journal of Biological Chemistry. 279(45). 47050–47056. 191 indexed citations
17.
Beutler, William, Colleen Sweeney, & Patrick J. Connolly. (2001). Recurrent Laryngeal Nerve Injury With Anterior Cervical Spine Surgery. Spine. 26(12). 1337–1342. 129 indexed citations
18.
Carroll, Eben A., et al.. (2001). Traumatic Atlantoaxial Distraction Injury. Spine. 26(4). 454–457. 19 indexed citations
19.
Wortmann, Glenn, et al.. (2001). Rapid diagnosis of leishmaniasis by fluorogenic polymerase chain reaction.. American Journal of Tropical Medicine and Hygiene. 65(5). 583–587. 86 indexed citations
20.
Sweeney, Colleen, et al.. (1999). Functional Outcome of Low Lumbar Burst Fractures. Spine. 24(20). 2154–2154. 88 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Raj K. Pandita Breakdown of academic impact, for papers by Susan Smith Breakdown of academic impact, for papers by Rodrigo Bravo Breakdown of academic impact, for papers by Homayoun Vaziri Breakdown of academic impact, for papers by Jun Kudoh Breakdown of academic impact, for papers by Ludger Klein‐Hitpaß Breakdown of academic impact, for papers by Kevin D. Brown Breakdown of academic impact, for papers by Jolene J. Windle Breakdown of academic impact, for papers by Robert P. C. Shiu Breakdown of academic impact, for papers by Qiang Wang
Rankless by CCL
2026